Zkusit zdarma
Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

KROS
Cena:
 
 
Valuace
70
Růst
15
Zdraví
75
preloader

Finanční výsledky Keros Therapeutics, Inc. (KROS)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS2.3-5-5.2-4.15-2.52
Gross Profit244.1M3.6M151000-20.1M
Net Income Attributable to Common Shareholders87M-187.4M-153M-104.7M-58.7M
Operating Profit67.6M-210.8M-169.9M-114.8M-56.4M
Total Revenues244.1M3.6M151000-20.1M